Page 61 - 林口長庚醫研部電子報-2019年3月刊

IF≧5或該領域前10%

PTPRT and PTPRD Deleterious Mutations and Deletion
Predict Bevacizumab Resistance in Metastatic Colorectal
Cancer Patients
CANCERS, SEP.2018

IF= 5.326(20.18 %)
第一作者：腫瘤科徐鴻智醫師
指導作者：直腸外科莊游正府醫師

Plasminogen activator inhibitor-1 is associated with the
metabolism and development of advanced colonic polyps
TRANSLATIONAL RESEARCH, OCT.2018

IF= 4.88(10%)
第一作者：胃腸肝膽科陳聰興醫師
指導作者：胃腸肝膽科張明鈴醫師

Pathological risk factors stratification in pN3b oral
cavity squamous cell carcinoma: Focus on the number of
positive nodes and extranodal extension

ORAL ONCOLOGY, NOV.2018
IF= 4.636(3.3 %)
第一作者：耳鼻喉科廖俊達醫師
病理科李麗玉醫師／薛純醫師
指導作者：核子醫學科閻紫宸醫師

61